ASPOCHALASIN E, A NEW ANTIBIOTIC ISOLATED FROM A FUNGUS
Nobuaki Naruse, Haruaki Yamamoto, Shinji Murata, Yosuke Sawada, Yasuo Fukagawa and Toshikazu Oki Bristol-Myers Squibb Research Institute, 2-9-3 Shimo-meguro, Meguro-ku, Tokyo 153, Japan (Received for publication December 8, 1992) In the course of screening for new biological actives, an unidentified fungal strain (FA2277) was found to produce several cytotoxic substances including a new aspochalasin analog. Aspochalasins which are structurally related to cytochalasins, well-known mycotoxins, were first isolated as metabolic products of Aspergillus microcysticusl\ and few compounds of this group have been characterized to date2'3). This paper briefly describes the fermentation, isolation, structural studies, and cytotoxic activity of aspochalasin E, a new aspochalasin analog ( Fig. 1 ). Strain FA2277 was isolated from a soil sample collected in Kawasaki City, Kanagawa Prefecture, Japan. A loopful spores of this strain was inoculated into a 500-ml Erlenmeyer flask containing 100 ml of vegetative mediumcomposedof soluble starch 2%, soybean meal 1% and CaCO3 0.5%, pH 7.0 before sterilization, and incubated at 28°C for 4 days on a rotary shaker (200rpm). For production of Scheme 1. Purification procedure of seven components.
Correspondence should be addressed to Jun Okumura, Bristol-Myers Squibb Research Institute, 2-9-3 Shimomeguro, Meguro-ku, Tokyo 153, Japan. antibiotics 5 ml of the culture was transferred into 500-ml Erlenmeyer flasks containing 100 ml each of fermentation mediumhaving the same composition as the vegetative medium.The fermentation was carried out at 28°C for 5 days on a rotary shaker. The isolation procedure of cytotoxic components from culture broth of strain FA2277 is schematically shown in Scheme 1. From the 1-butanol extract of the fermentation broth (9.6 liters), components A (499mg), B (710mg), C (3mg), D (60mg), E (82mg), F (195mg) and G (28mg) were isolated as homogeneous powders.
Components A, C, D, F and G were all revealed to be curvularin-type metabolites and were spectroscopically identified as known a,/?-dehydrocurvularin (component A)4) and the stereoisomers of j8-methoxycurvularin (C, D)5>6) and /Miydroxycurvularin (F, G)7>8). On the other hand, both components B (1) and E (2) contained nitrogen atoms in their molecules and were shown to belong to the aspochalasin group of antibiotics. 1 was deduced to be aspochalasin C3) by spectroscopic analyses.
The physico-chemical properties of component E
(2) are summarized in Table 1 . The molecular formula of 2, C24H37NO5, determined by HRFAB-MSindicates that 2 is a hydroxylated compound of aspochalasin C or D. The 13C and *H NMRdata of2 are presented in Table 2 . All one-bond XH-13C correlations were established by XH-13C COSY spectrometry, indicating the presence of two separate spin systems as shown in Fig. 2 . The long-range XH-13C COSY spectrum (12Hz, Fig. 2 ) allows to connect these two partial structures, leading to the planar structure of 2 as a 19-hydroxy analog of aspochalasin C or D (Fig. 1) . Although the stereochemical studies of 2 has not yet been performed, 2 is assumed to have the same stereochemistry as co-produced aspochalasin C (1) or D. Accordingly the nameof aspochalasin E is proposed for 2.
Seven components all inhibited the growth of murine melanoma B16-F10 and human colon carcinoma HCT-116 cells. The IC50 values of aspochalasin E (2) and component B (1) are listed in Table 3. 
